Shearman & Sterling LLP | USA | 18 Jan 2023
On January 11, 2023, the United States District Court for the Northern District of California dismissed a putative class action asserting claims…
Cozen O'Connor | USA | 4 Oct 2018
State Attorneys General (“AGs”) continue to be active as both litigants and amici in cases before the U.S. Supreme Court. This term there are several…
BoyarMiller | USA | 22 Jul 2011
On July 13, 2011, the Wall Street Journal's Law Blog referenced a report about the increased number of class action lawsuits seeking damages for lost share value filed by investors against companies involved in mergers and acquisitions.
Orrick, Herrington & Sutcliffe LLP | USA | 6 Oct 2010
On September 22, 2010, the U.S. Court of Appeals for the Sixth Circuit affirmed dismissal of a class action lawsuit brought by shareholders of Accredo Health Group, Inc. against Ernst & Young LLP for failure to make a case that Ernst & Young committed fraud in audit reports issued in connection with Accredo's acquisition of Gentiva Health Services, Inc.
Potter Anderson & Corroon LLP | USA | 9 Jul 2009
In a matter of first impression, the Delaware Supreme Court determined the appropriate remedy for a “short form” merger under 8 Del. C. § 253, where a corporation’s minority stockholders are cashed out without the controlling stockholder disclosing information material to a stockholder’s decision whether to seek appraisal.
Squire Patton Boggs | USA | 20 May 2009
A recent decision by the Delaware Supreme Court in Lyondell Chemical Co. v. Ryan made several important clarifications about the nature of the fiduciary duties that corporate directors owe in connection with the sale of Delaware corporations.
Locke Lord LLP | USA | 3 Apr 2009
The United States District Court for the District of Massachusetts has denied a motion to dismiss a class action claiming that certain private equity firms illegally colluded in the purchase of target companies in leveraged buyout transactions.
Alston & Bird LLP | USA | 20 Mar 2009
In a recent decision underscoring the importance of the Supreme Court’s decision in Dura Pharmaceuticals, Inc. v. Broudo, 544 U.S. 336, 342 (2005), the United States Court of Appeals for the Tenth Circuit affirmed summary judgment because the plaintiffs’ expert could not articulate a reliable theory of loss causation.
Potter Anderson & Corroon LLP | USA | 22 Jan 2009
In this case, Vice Chancellor Lamb approved a settlement effecting changes to a merger agreement between the Wm. Wrigley Jr. Company and Mars, Inc.